- Nachrichtendetail
-
09.04.2024 12:50:53 - dpa-AFX: *PFIZER SAYS PHASE 3 ABRYSVO STUDY MEETS TRIAL PRIMARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 28,880 | 24.05.24 03:00:45 | +0,190 | +0,66% | 28,870 | 28,910 | 28,665 | 28,880 |
